Valeant's Papa: 'It's been a challenging 15 months, but we've made great progress'

7:18 PM ET Wed, 16 Aug 2017

Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker's turnaround.